Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kali bichromicum is the homeopathic name for highly diluted preparations of potassium dichromate, a chemical compound with the formula K₂Cr₂O₇. In homeopathy, it is used primarily for conditions involving thick, stringy mucus and complaints of the mucous membranes in areas such as the nose, throat, stomach, and ear. The original substance—potassium dichromate—is a caustic industrial chemical and known poison; however, in homeopathic remedies it is diluted to non-toxic levels through serial dilution and succussion (shaking). The mechanism of action according to conventional pharmacology is not established due to extreme dilutions; its use relies on traditional homeopathic principles rather than evidence-based medicine. It has been studied in some clinical settings for effects on tracheal secretions in mechanically ventilated patients but lacks FDA approval or scientific consensus regarding efficacy[1][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kali bichromicum.